Overview
Kirby-Bauer testing places antimicrobial-impregnated disks on a standardized lawn of bacteria on Mueller-Hinton agar and measures zones of inhibition after incubation.
Clinical Importance
Determine susceptible/intermediate/resistant (or S/I/R and area-of-technical-uncertainty categories per current tables) interpretations for therapy guidance
Provide a reference phenotypic AST method and backup to automated systems
Specimen Requirements
- Specimen: pure culture isolate of the organism to be tested
- Inoculum: prepare to the McFarland standard specified by the method (commonly 0.5 McFarland for many disk/MIC methods)
- Media: use CLSI/EUCAST-recommended medium (e.g., Mueller-Hinton agar ± blood for fastidious organisms)
- Controls: include QC organisms on the validated schedule
Analytical Method
A 0.5 McFarland inoculum is swabbed onto Mueller-Hinton agar; disks are applied; plates incubate under specified conditions. Zone diameters are measured and interpreted using current CLSI M100 or EUCAST breakpoint tables adopted by the laboratory.
Instruments Used
Automated analyzers
- bioMérieux VITEK 2 AST cards
- Beckman Coulter MicroScan WalkAway AST panels
- BD Phoenix AST panels
- Gradient strip (Etest-class) readers in selected workflows
Manual methods
- Manual Kirby-Bauer disk diffusion
- Manual broth microdilution / agar dilution MIC
- Manual gradient diffusion (Etest) reading
Reference Values
Microbiology results are interpreted against organism identification, specimen quality, clinical context, and current CLSI and/or EUCAST interpretive criteria (including CLSI M100 for susceptibility where adopted). Reporting conventions and critical-notification lists are institution-defined; verify against the performing laboratory SOP and current guideline editions.
There is no universal numeric reference interval. Interpretive breakpoints are drug-, organism-, and guideline-version-specific (CLSI M100 / EUCAST).
QC ranges for control strains must fall within published limits before patient results are released.
Interpretation
Critical and significant-risk microbiology findings (e.g., positive blood culture, CSF pathogen) follow institutional urgent-notification pathways. Confirm the local call list. Textbook examples are not universal thresholds.
Critical values
- Unexpected resistance patterns (e.g., carbapenem-resistant Enterobacterales) often require urgent notification and confirmation
Common Causes of Increased Results
- Large zones generally indicate greater inhibition in vitro; interpret only with official breakpoints (not by zone size intuition alone)
Common Causes of Decreased Results
- Small or no zones may indicate resistance; confirm with MIC methods when required by SOP or for critical drugs
Clinical Significance
- Routine AST for many rapidly growing aerobic bacteria
- Confirmation or problem-solving when automated AST is inconclusive
Factors Affecting Results
Pre-analytical
- Incorrect McFarland inoculum (too heavy shrinks zones)
- Expired disks or improper disk storage
Analytical
- Agar depth outside 4 mm recommendation
- Incubation time/atmosphere errors
- Measuring zones from colony edge incorrectly
Post-analytical
- Using outdated breakpoint tables
- Applying breakpoints to organisms without validated criteria
Advantages and Limitations
Advantages
- Flexible drug panel selection
- Visual detection of some inducible/heteroresistance clues
- Lower capital cost than automated systems
Limitations
- Manual labor and measurement variability
- Not suitable for all organism–drug combinations
- Slower reporting than some automated overnight systems
Clinical Pearls
A pretty zone means nothing without this year’s breakpoint table . AST is a moving regulatory target.
References
Authoritative textbooks, guidelines, and reviews supporting this laboratory test reference. Verify reference intervals, critical limits, and method details against institutional protocols and current guideline editions.
Textbooks
- Carroll KC, Pfaller MA, Landry ML, et al., eds. Manual of Clinical Microbiology. ASM Press (verify current edition).
- Forbes BA, Sahm DF, Weissfeld AS. Bailey & Scott's Diagnostic Microbiology. 15th ed. Elsevier; 2020.
- Mahon CR, Lehman DC, Manuselis G. Textbook of Diagnostic Microbiology. 6th ed. Elsevier; 2018.
- Carroll KC, Hobden JA, Miller S, et al. Jawetz, Melnick, & Adelberg's Medical Microbiology. 28th ed. McGraw-Hill; 2019.
- Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology. 9th ed. Elsevier; 2021.
CLSI and Professional Guidelines
- Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. CLSI document M100 (verify current edition and institutional adoption).
- Centers for Disease Control and Prevention / NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL). Current edition (verify institutional adoption).
- Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. CLSI document M100 (verify current edition and institutional adoption).
- Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests. CLSI document M02 (verify current edition).
- Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. CLSI document M07 (verify current edition).
- European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables and documents (verify current version and institutional adoption).
WHO Publications
- World Health Organization. Laboratory and diagnostic guidance relevant to clinical microbiology practice (verify current WHO publication for the method).
Frequently Asked Questions
Common questions about using this Kirby-Bauer Disk Diffusion laboratory test Medical Laboratory Library reference in Medical Laboratory Science education.
What is the Kirby-Bauer Disk Diffusion laboratory test reference used for?
This Medical Laboratory Library page summarizes the clinical importance of Kirby-Bauer Disk Diffusion. Review the Clinical Importance section for why the test is ordered in laboratory medicine practice.
Where can I find Kirby-Bauer Disk Diffusion specimen requirements?
See the Specimen Requirements section on this page for specimen information related to Kirby-Bauer Disk Diffusion. Confirm collection details against your laboratory protocol.
Where are Kirby-Bauer Disk Diffusion reference values listed?
See the Reference Values section on this Laboratory Library page. Reference ranges can vary by method and population, so verify intervals with your laboratory.
How do I interpret Kirby-Bauer Disk Diffusion results?
Use the Interpretation section for laboratory interpretation framing, including increased and decreased result patterns when provided. Do not treat educational text as a patient-specific diagnosis.
What analytical method is used for Kirby-Bauer Disk Diffusion?
See the Analytical Method section for principle and method notes. Method details may differ by instrument and institutional SOP.
Are related laboratory tests linked from Kirby-Bauer Disk Diffusion?
Yes. The Related Laboratory Tests section lists connected references for continued lookup in the Medical Laboratory Library.
How can I continue learning after reading Kirby-Bauer Disk Diffusion?
Use Continue learning links on this page for related Academy lessons, medical laboratory quizzes, or laboratory case studies when available for this Medical Microbiology topic.
What are the clinical pearls for Kirby-Bauer Disk Diffusion?
See the Clinical Pearls section for concise laboratory practice notes associated with Kirby-Bauer Disk Diffusion. Apply pearls alongside institutional protocols.
Reading progress
Awards XP once after you have meaningfully reviewed this article.